EU SPC Manufacturing Waiver Becomes Effective: What Can Industry Expect? Journal Artikel Philipp Cepl, Marco de Morpurgo, Chiara Perotti European Pharmaceutical Law Review, Jahrgang 3 (2019), Ausgabe 3, Seite 116 - 120
Are You AI’S Favourite? EU Legal Implications of Biased AI Systems in Clinical Genetics and Genomics Anastasiya Kiseleva, Paul Quinn
A Case of Unforeseen Adverse Side-Effects? The Ireland/Northern Ireland Protocol and Medicines Regulation George Peretz, Xisca Borrás